NCT05535543 Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
| NCT ID | NCT05535543 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Acute Respiratory Distress Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-09-06 |
| Primary Completion | 2025-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2022-09-06 with a primary completion date of 2025-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effects of prone positioning on homogenization of ventilation.
Eligibility Criteria
Inclusion Criteria: * ARDS criteria met * intubated and mechanically ventilated as a result of respiratory failure * PaO2/FiO2 \<200 Exclusion Criteria: * age older than 18 * Chronic pulmonary disease, pneumothoraces, intraabdominal hypertension (\> 12 mmHg), pregnancy, not expected to survive \>24 hours, hemodynamic instability
Contact & Investigator
Olcay Dilken, MD
PRINCIPAL INVESTIGATOR
Hamidiye Etfal Hospital
Frequently Asked Questions
Who can join the NCT05535543 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Respiratory Distress Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05535543 currently recruiting?
Yes, NCT05535543 is actively recruiting participants. Contact the research team at olcaydilken@gmail.com for enrollment information.
Where is the NCT05535543 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT05535543 clinical trial?
NCT05535543 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Olcay Dilken, MD at Hamidiye Etfal Hospital. The trial plans to enroll 60 participants.